Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126366611 | 12636661 | 1 | I | 20160726 | 20160809 | 20160809 | EXP | JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-121688 | RANBAXY | 58.00 | YR | F | Y | 0.00000 | 20160809 | OT | GB | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126366611 | 12636661 | 1 | SS | PACLITAXEL. | PACLITAXEL | 1 | Unknown | TWO CYCLES | Y | U | 0 | ||||||||
126366611 | 12636661 | 2 | SS | VINORELBINE | VINORELBINEVINORELBINE TARTRATE | 1 | Unknown | TWO CYCLES | Y | U | 0 | ||||||||
126366611 | 12636661 | 3 | PS | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | TWO CYCLES | Y | U | 77926 | ||||||||
126366611 | 12636661 | 4 | SS | CISPLATIN. | CISPLATIN | 1 | Unknown | TWO CYCLES | Y | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126366611 | 12636661 | 1 | Lung adenocarcinoma stage III |
126366611 | 12636661 | 2 | Lung adenocarcinoma stage III |
126366611 | 12636661 | 3 | Lung adenocarcinoma stage III |
126366611 | 12636661 | 4 | Lung adenocarcinoma stage III |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126366611 | 12636661 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126366611 | 12636661 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |